Differential expression of specific microRNA and their targets in acute myeloid leukemia
β Scribed by Giuseppe Cammarata; Luigi Augugliaro; Domenico Salemi; Cecilia Agueli; Maria La Rosa; Lea Dagnino; Gabriele Civiletto; Francesca Messana; Anna Marfia; Maria Grazia Bica; Lucia Cascio; Pietro Michele Floridia; Angelo M. Mineo; Mario Russo; Francesco Fabbiano; Alessandra Santoro
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 560 KB
- Volume
- 85
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Specific expression of different CD45 isoforms can be seen in various stages of differentiation of normal nucleated hematopoietic cells. Association of membrane expression of CD45 isoforms and differential levels of leukemia cells was studied in 91 cases with de novo acute myeloid leukemia (AML
## Abstract Acute myeloid leukemia (AML) is a malignant disease of hematopoietic cells whose emergence, course, and prognosis is affected by specific recurrent genetic alterations like chromosome aberrations and point mutations, as well as by changes in the expression of certain genes. In the past
## Abstract Specific immunotherapies for patients with acute myeloid leukemia (AML) using leukemiaβassociated antigens (LAA) as target structures might be a therapeutic option to enhance the graftβ__vs__.βleukemia effect observed after allogeneic stem cell transplantation or to prolong a complete r
CD7 antigen, a T-cell lineage associated antigen, is expressed in a minority of patients with acute myeloid leukemia (AML). The biologic and clinical significance of this finding is not clearly established. In this retrospective study of patients with de novo acute myeloid leukemia, we have identifi